炎症性腸疾患の患者における血細胞性リンパヒスティオシトーシス: 系統的レビュー
Tingwei Lan1, Qinhuan Luo1, Xiaojuan Guo2
1Tsinghua University, Tsinghua Medicine, School of Medicine, Beijing, China.
Frontiers in immunology
|September 2, 2025
まとめ
炎症性腸疾患 (IBD) の患者では,感染症やリンパ腫によって引き起こされる二次性HLH (sHLH) としてしばしば表れます. 生存率は62. 5%だが,ほとんどの患者はIBD治療を成功裏に再開する.
科学分野:
- 胃腸内科と免疫学
- 血液学
- 腫瘍学
背景:
- 炎症性腸疾患 (IBD) の患者は,生命を脅かす高炎症症症候群である血細胞性リンパヒスティオサイトーシトーシス (HLH) のリスクが高くなります.
- IBD患者におけるHLHの根本的なメカニズム,臨床的特徴,および治療法は,特に免疫抑制療法については十分に理解されていません.
研究 の 目的:
- 炎症性腸疾患の患者におけるHLHの流行病学,臨床表現,管理,アウトカムを体系的に検討し,特徴づけること.
- IBDの文脈で二次性HLH (sHLH) と一次性HLHの特徴と結果を区別する.
主な方法:
- PubMed,Web of Science,およびEmbaseのデータベースを使用して,体系的な文献レビューが行われました.
- IBD患者の97例の二次性HLHと18例の一次性HLHのデータを分析した.
主要な成果:
- IBDにおける二次性HLHは,主にクローン病の男性で,平均年齢は33. 5歳で,チオプリン療法によるIBD寛解中にしばしば発生します.
- 感染 (CMV,EBV) とリンパ腫は,sHLHの一般的なトリガーでした. sHLHの全生存率は62. 5%で,ほとんどの患者は5ヶ月以内にIBD治療を再開しました.
- sHLHにおける死亡率に関連した要因には,高齢者,リンパ腫トリガー,および生物学的治療またはチオプリン治療の欠如が含まれる. 主要なHLH患者はより若く,HSCTでよりよい結果を示しました.
結論:
- この体系的レビューは,IBD患者におけるHLHの包括的な特徴を提供し,sHLHの独特な特徴を強調しています.
- 発見は,この脆弱な患者グループの成果を向上させるための改善された臨床管理と将来の研究方向性のための洞察を提供します.
関連する概念動画
Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185
Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206


